Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Markets
Stocks
F&O
Mutual Funds
ETFs
More
Research
Pricing
Resources

Sector: Pharmaceuticals & Biotechnology

Small Cap

Bharat Immunological Share Price

Q: What is the Market Capitalization of Bharat Immunological & Biologicals Corporation Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Bharat Immunological & Biologicals Corporation Ltd. is approximately ₹ 72.6 Cr.

Q: What are the PE and PB ratios for Bharat Immunological & Biologicals Corporation Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Bharat Immunological & Biologicals Corporation Ltd. is -3.9, and the Price-to-Book (PB) ratio is 0.8.

Q: What is the 52-Week High and Low for Bharat Immunological & Biologicals Corporation Ltd.?

Over the past 52 weeks, the highest price reached by Bharat Immunological & Biologicals Corporation Ltd. shares was ₹ 28.8, and the lowest price was ₹ 14.1.

Q: Who are the major shareholders of Bharat Immunological & Biologicals Corporation Ltd.?

Significant shareholdings in Bharat Immunological & Biologicals Corporation Ltd. typically include entities such as: Promoter Public Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Bharat Immunological & Biologicals Corporation Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Bharat Immunological & Biologicals Corporation Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.

Q: What is the shareholding pattern for Bharat Immunological & Biologicals Corporation Ltd.?

As per the filings for the quarter ending Quarter, the approximate shareholding pattern for Bharat Immunological & Biologicals Corporation Ltd. is: Promoters: Promoter Holding (%)% Domestic Institutional Investors (DII): Holding (%)% Foreign Institutional Investors (FII): Holding (%)% Others (including Public): Holding (%)%

Bharat Immunological & Biologicals Corporation Ltd.

₹17.10

1.34(8.50%)

Trade Now

2nd Apr 2026 | 3:27 PM

NSE :

Open Free Demat Account

Bharat Immunological Performance

Price Movement

N/A

₹15.21

₹17.41

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹17.41

Low₹15.21

Open at₹15.30

Prev Close₹15.76

Volumes37.74 K

Avg Price₹16.61

Lower Circuit₹12.61

Upper Circuit₹18.91

Historical Performance

3M High₹21.88

3M Low₹14.10

1 Yr High₹28.80

1 Yr Low₹14.10

3 Yr High₹43.89

3 Yr Low₹14.10

5 Yr High₹94.50

5 Yr Low₹14.10

Bharat Immunological Fundamentals

Market Cap

Below industry Median

72.60 Cr.

PE Ratio (TTM)

Negative PE TTM

-3.90

Dividend Yield

Net Profit TTM

97% decr over last year

-18.48

Net Profit Growth

97% decr over last year

-18.48

PEG Ratio

Below industry Median

ROE

134% decr over last year

-19.42

Operating Revenue TTM

7.65

Operating Revenue Growth

90% decr over last year

Book Value

Below industry Median

0.80

MFI

MFI is mid-range

35.79

RSI

RSI is mid-range

50.20

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

0.80

Bharat Immunological Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022
Total Revenue	0	0	7.65	0	26.48
Operating Expense	4.69	4.31	14.06	4.73	28.98
Operating Profit	-4.69	-4.31	-6.41	-4.73	-2.50
Depreciation	0.03	0.03	0.04	0.04	0.04
Interest	2.09	1.72	2.05	1.67	1.74
Tax	-1.73	-1.38	-1.97	-1.65	-0.88
Net Profit	-4.92	-4.59	-4.29	-4.68	-3.08

Bharat Immunological Technicals

Bharat Immunological & Biologicals Corporation Ltd. EMA & SMA

₹17.10

1.34 (8.50%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹16

Day EMA10 ₹16.1

Day EMA12 ₹16.2

Day EMA20 ₹16.5

Day EMA26 ₹16.8

Day EMA50 ₹17.5

Day EMA100 ₹18.5

Day EMA200 ₹20.1

Bharat Immunological Support and Resistance

Resistance

First Resistance₹17.75

Second Resistance₹18.68

Third Resistance₹19.95

Support

First Support₹15.55

Second Support₹14.28

Third Support₹13.35

Technical Indicators

Day RSI50.20

Day MFI35.79

Day ADX11.68

Day Commodity Channel Index-11.50

William-30.26

Day MACD-0.57

Day MACD Signal Line-0.57

Day ATR1.21

Day ROC125-21.55

Day ROC21-6.56

Bharat Immunological Shareholding Pattern

Held By
Promoter
FII
DII
Public

Bharat Immunological Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	26.67 K	34.06 K	78.31%
Week	48.62 K	63.54 K	76.52%
1 Month	24.02 K	33.83 K	71.01%
6 Month	18.79 K	25.6 K	73.39%

Bharat Immunological SWOT Analysis

Strengths6

Weakness11

Opportunity0

Threats0

Positive Breakout First Resistance ( LTP > R1)

PEG lower than Industry PEG

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Biggest Price Gainers from Open

Top Gainers

Bharat Immunological Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Bharat Immunological Stock Comparison

Financials	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Aptus Pharma Ltd.	Amanta Healthcare Ltd.
Price (₹)	₹201.95	₹37.60	₹5.80	₹89.80	₹345.05	₹108.50
% Change	-1.49%	1.98%	4.88%	-10.11%	-0.00%	2.54%
Revenue TTM (₹ Cr)	-	₹0.54	₹83.60	-	-	₹282.74
Net Profit TTM (₹ Cr)	-	₹-0.24	₹-34.95	-	-	₹15.30
PE TTM	56.00	-95.60	-1.40	11.90	76.40	27.40
1 Year Return		735.56	479	-29.73		-14.23
ROCE	-	-	-5.63	-	-	-

Similar Stocks

AHCL

Anlon Healthcare Ltd.

₹ 112.60

-0.42%

MEDISTEP

Medistep Healthcare Ltd.

₹ 17.20

+0.00%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 59.50

+2.06%

APL

Asston Pharmaceuticals Ltd.

₹ 78.00

-1.02%

INFLUX

Influx Healthtech Ltd.

₹ 214.00

+0.19%

MEDIORG

Medicamen Organics Ltd.

₹ 23.25

+4.97%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 507.95

+1.69%

ASTONEALAB

Astonea Labs Ltd.

₹ 159.60

+0.00%

AMWILL

Amwill Health Care Ltd.

₹ 31.79

+4.61%

SENORES

Senores Pharmaceuticals Ltd.

₹ 785.00

+1.48%

INNOVACAP

Innova Captab Ltd.

₹ 703.90

-0.01%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 56.10

-1.48%

SHELTER

Shelter Pharma Ltd.

₹ 29.35

-1.44%

TLL

Trident Lifeline Ltd.

₹ 263.50

-1.03%

DPL

Dipna Pharmachem Ltd.

₹ 9.00

-2.70%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.65

+0.53%

FABINO

Fabino Enterprises Ltd.

₹ 16.73

+4.96%

SUPRIYA

Supriya Lifescience Ltd.

₹ 611.00

+1.66%

SIGACHI

Sigachi Industries Ltd.

₹ 19.45

-0.10%

WINDLAS

Windlas Biotech Ltd.

₹ 766.00

-0.21%

VINEETLAB

Vineet Laboratories Ltd.

₹ 29.50

+0.10%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 32.00

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 474.80

+3.42%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.45

+2.27%

FAQ's on BIBCL

What is the Market Capitalization of Bharat Immunological & Biologicals Corporation Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Bharat Immunological & Biologicals Corporation Ltd. is approximately ₹ 72.6 Cr.

What are the PE and PB ratios for Bharat Immunological & Biologicals Corporation Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Bharat Immunological & Biologicals Corporation Ltd. is -3.9, and the Price-to-Book (PB) ratio is 0.8.

What is the 52-Week High and Low for Bharat Immunological & Biologicals Corporation Ltd.?

Over the past 52 weeks, the highest price reached by Bharat Immunological & Biologicals Corporation Ltd. shares was ₹ 28.8, and the lowest price was ₹ 14.1.

Who are the major shareholders of Bharat Immunological & Biologicals Corporation Ltd.?

Significant shareholdings in Bharat Immunological & Biologicals Corporation Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Bharat Immunological & Biologicals Corporation Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Bharat Immunological & Biologicals Corporation Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.